Using the computational pharmacophore-based ANCHOR.QUERY platform a new scaffold was discovered. Potent compounds evolved inhibiting the protein-protein interaction p53-MDM2. An extensive SAR study was performed based on our four-point pharmacophore model, yielding derivatives with affinity to MDM2 in the nanomolar range. Their binding affinity with MDM2 was evaluated using both fluorescence polarization
使用基于计算药效团的ANCHOR.QUERY平台,发现了一种新的支架。进化出有效的化合物可抑制蛋白质与蛋白质的相互作用p53-M
DM2。基于我们的四点药效团模型进行了广泛的
SAR研究,得出了与M
DM2亲和力在纳摩尔范围内的衍
生物。使用荧光偏振(FP)分析和2D-NMR-HSQC实验评估了它们与M
DM2的结合亲和力。